MAY 29, 2014 7:30 AM PDT

Is Cervical Cancer a preventable Disease in women? The role of HPV as a screening test.

Speaker
  • Professor of Pathology, Contract Staff - Clinical & Molecular Virology. Center of Pediatric Research, Cleveland Clinic, Cleveland, Ohio
    Biography
      Belinda Yen-Lieberman, Ph.D., is a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine. She is board certified in clinical virology (Am Society for Clinical Pathology). Dr. Yen-Lieberman received her Bachelor of Science degree in microbiology from Southern Illinois University and her Master of Science and Doctorate degrees in Immunology and biochemistry at the University of Arkansas, Fayetteville, Arkansas. She completed fellowships in clinical and cellular immunology at Case Western Reserve University and the Cleveland Clinic Foundation.

      Dr. Yen-Lieberman has authored over one hundred thirty articles for numerous medical journals on a wide range of topics involving viruses and infectious disease, including studies involving HIV, Hepatitis B , Hepatitis C and Influenza A vaccine, tests for herpes simplex types 1 and 2, and tuberculosis. For the past 24 years, she was the medical director of clinical and Molecular Virology and Serology in Department of Laboratory Medicine. Since July 2015, Dr. Yen-Lieberman is a contract staff in Lab Medicine and Center for Pediatric Research (as clinical virologist). She is responsible for teaching Pathology residents, medical students in CCLCM and students from Cleveland Clinic Medical Technology School. She also participates in various clinical trial studies and research projects including the role of respiratory viruses in childhood asthma.

    Abstract

    Human papillomavirus (HPV) is the primary cause of cervical cancer and more than 100 types of HPV have been identified. Detection of HPV from cervical samples is associated with a 250 times increased risk of high grade cervical neoplasm. Approximately 30 HPV types were reported to infect primarily the squamous epithelium of the lower anogenital tracts of men and women. Worldwide, Cervical Cancer is much more common particularly in countries without screening programs, with an estimated 530,000 new cases of the disease and 275,000 resultant deaths each year (Farlay J, et al. 2008 and Arbyn M, et al 2011). When cervical cancer screening programs have been introduced into communities, marked reductions in cervical cancer incidence have followed (Gustafsson L, et al 1997).

    Human Papillomavirus is one of the most common sexually transmitted infections (STI) in the United States in women, with approximately 6.2 million cases diagnosed annually. The American Cancer Society estimates that there will be 12,170 new cases of cervical cancer in the United States in 2012, with 4,220 deaths from the disease ( Siegel R et al. 2012).

    Learning Objectives:

    At the completion of the presentation, the learners should know:
    1. What is Human Papilloma virus (HPV)
    2. HPV is the primary causal factor of cervical cancer and cervical disease in Women
    3. HPV is one of the most common sexually transmitted infections the the USA
    4. HPV vaccines are available for young men and young women
    5. Why is HPV testing important in women?


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    AUG 18, 2020 10:00 AM PDT
    C.E. CREDITS
    AUG 18, 2020 10:00 AM PDT
    DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources
    Attendees
    • See more